News

IMB researchers and Dr Luregn Schlapbach from the Lady Cilento Children's Hospital are fighting sepsis through developing better diagnostics

A promising new therapy to stop Parkinson's disease, the second-most common neurodegenerative disease worldwide, with 10 million sufferers.

A project using molecules from spider venom to develop improved treatments for chronic pain and stroke will be undertaken by Institute for Molecular Bioscience (IMB) Professor Glenn King in partnership with University of Science and Technology of China, after receiving funding from the Queensland Government.

Researchers have used human stem cells and single-cell sequencing to uncover the complex choreography of heart development

Researchers from The University of Queensland (UQ) and the University of Münster (WWU) have purified and visualized the ‘Cyclic Electron Flow’ (CEF) supercomplex, a critical part of the photosynthetic machinery in all plants, in a discovery that could help guide the development of next-generation solar biotechnologies. 

Researchers have solved the structure of a complex molecular machine responsible for sorting and transporting cellular cargo.

Venom from the giant red bull ant is helping IMB scientists understand the evolution of animal toxins in work that could lead to better treatments for pain.

A University of Queensland research discovery reveals how the body puts the brakes on inflammation, a discovery that will help us understand how poorly controlled inflammation exacerbates diseases including cystic fibrosis, Alzheimer’s, atherosclerosis and cancer.

Professor Glenn King and partners have discovered a peptide in the venom of funnel-web spiders that could drastically reduce brain damage following stroke.

For the first time, scientists have seen in exquisite, real-time detail how immune cells survey their surroundings to detect threats to our health.

Associate Professor Kate Schroder and her team uncovered a new line of defence deployed by the immune system against bacteria.

Two IMB researchers are among a group of 100 female scientists from around the world taking part in a year-long leadership scheme culminating in an Antarctic voyage.

Researchers from the Institute for Molecular Bioscience have revealed the genetic causes of neurological degeneration, which could be a key to slowing the progression of devastating diseases including cerebellar ataxias and neurodegenerative conditions.

Researchers have revealed how immune cells are prompted to release the protein interleukin-1beta, in a discovery that gives new insight into how our immune systems drives diseases such as auto-inflammatory diseases, arthritis and gout.

A peptide from the venom of the spider Heteroscoda maculata can restore the neural deficiencies that trigger seizures associated with Dravet syndrome, a devastating form of childhood epilepsy.

A short-statured population of Indonesians living on the island of Flores arose independently of the extinct species Homo floresiensis – the so-called ‘hobbits’ – an international team of scientists has found.

Geneticists Professor Peter Visscher and Professor Jian Yang have had their work recognised by prestigious funding from the ARC.

The largest genetic study of type 2 diabetes has identified 42 new genetic variants in a discovery that could provide new opportunities to prevent and treat this disease.

Research into a toxin from the desert bush spider could lead to new treatments for conditions such as pain, cardiac arrhythmia and epilepsy, and could also advance the development of ecofriendly insecticides.

University of Queensland scientists have identified genes associated with fatty liver disease, a condition affecting 5.5 million Australians.